Clinical Trial: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.

U.S., April 22 -- ClinicalTrials.gov registry received information related to the study (NCT07543224) titled 'A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of RSS0393 Ointment in Adult Patients With Plaque Psoriasis.' on April 07.

Brief Summary: Phase III Efficacy and Safety Study of RSS0393 Ointment in Plaque Psoriasis.

Study Start Date: April, 2026

Study Type: INTERVENTIONAL

Condition: Plaque Psoriasis Subjects

Intervention: DRUG: RSS0393 ointment 0.03%

RSS0393 ointment 0.03%

DRUG: RSS0393 ointment placebo

RSS0393 ointment placebo

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Reistone Biopharma Company Limited

Published by HT Digital Content Services...